Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer

Breast cancer is one of the common malignancies with poor prognosis worldwide. The treatment of breast cancer patients includes surgery, radiation, hormone therapy, chemotherapy, targeted drug therapy and immunotherapy. In recent years, immunotherapy has potentiated the survival of certain breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Bi, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034161/
https://www.ncbi.nlm.nih.gov/pubmed/36969235
http://dx.doi.org/10.3389/fimmu.2023.1164514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034161/
https://www.ncbi.nlm.nih.gov/pubmed/36969235
http://dx.doi.org/10.3389/fimmu.2023.1164514

Ejemplares similares